✦ LIBER ✦
WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial
✍ Scribed by Hofmann, Daniel; Nitz, Ulrike; Gluz, Oleg; Kates, Ronald E; Schinkoethe, Timo; Staib, Peter; Harbeck, Nadia
- Book ID
- 121625224
- Publisher
- BioMed Central
- Year
- 2013
- Tongue
- English
- Weight
- 879 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1468-6708
No coin nor oath required. For personal study only.